Vaso-occlusive and prothrombotic mechanisms associated with tumor hypoxia, necrosis, and accelerated growth in glioblastoma.
about
Exciting new advances in neuro-oncology: the avenue to a cure for malignant gliomaBcl2L12 inhibits post-mitochondrial apoptosis signaling in glioblastomaVascular heterogeneity and targeting: the role of YKL-40 in glioblastoma vascularizationMathematical Modelling of a Brain Tumour Initiation and Early Development: A Coupled Model of Glioblastoma Growth, Pre-Existing Vessel Co-Option, Angiogenesis and Blood PerfusionA critical balance: managing coagulation in patients with glioma.Pyruvate dehydrogenase kinase as a potential therapeutic target for malignant gliomas.Stat3 activation is required for the growth of U87 cell-derived tumours in miceCXCL12 modulation of CXCR4 and CXCR7 activity in human glioblastoma stem-like cells and regulation of the tumor microenvironment.Identification of ATP citrate lyase as a positive regulator of glycolytic function in glioblastomasIxolaris, a tissue factor inhibitor, blocks primary tumor growth and angiogenesis in a glioblastoma model.Derived vascular endothelial cells induced by mucoepidermoid carcinoma cells: 3-dimensional collagen matrix model.Current review of in vivo GBM rodent models: emphasis on the CNS-1 tumour model.A patient with multiple synchronous gliomas of distinctly different grades and correlative radiographic findingsCUSP9* treatment protocol for recurrent glioblastoma: aprepitant, artesunate, auranofin, captopril, celecoxib, disulfiram, itraconazole, ritonavir, sertraline augmenting continuous low dose temozolomide.Brain tumor cells in circulation are enriched for mesenchymal gene expressionBrain neoplasms and coagulation-lessons from heterogeneity."Occult" post-contrast signal enhancement in pediatric diffuse intrinsic pontine glioma is the MRI marker of angiogenesis?Extracellular vesicles as prospective carriers of oncogenic protein signatures in adult and paediatric brain tumours.EGFR gene overexpression retained in an invasive xenograft model by solid orthotopic transplantation of human glioblastoma multiforme into nude mice.The interplay of cell-cell and cell-matrix interactions in the invasive properties of brain tumorsHypoxia triggers a proangiogenic pathway involving cancer cell microvesicles and PAR-2-mediated heparin-binding EGF signaling in endothelial cells.Galectin-3 up-regulation in hypoxic and nutrient deprived microenvironments promotes cell survivalInhibitors of Glioma Growth that Reveal the Tumour to the Immune System.Diffusion MR Imaging of the Brain in Patients with CancerBevacizumab impairs oxidative energy metabolism and shows antitumoral effects in recurrent glioblastomas: a 31P/1H MRSI and quantitative magnetic resonance imaging studyDifferential microstructure and physiology of brain and bone metastases in a rat breast cancer model by diffusion and dynamic contrast enhanced MRI.Hypoxia and the hypoxia-inducible-factor pathway in glioma growth and angiogenesis.Downregulation of programmed cell death 10 is associated with tumor cell proliferation, hyperangiogenesis and peritumoral edema in human glioblastoma.P14ARF inhibits human glioblastoma-induced angiogenesis by upregulating the expression of TIMP3.Spatial Metrics of Tumour Vascular Organisation Predict Radiation Efficacy in a Computational Model.The tick-derived inhibitor Ixolaris prevents tissue factor signaling on tumor cells.Characterization of highly proliferative secondary tumor clusters along host blood vessels in malignant gliomaGlioblastoma multiforme: Molecular characterization and current treatment strategy (Review).Combined local blood-brain barrier opening and systemic methotrexate for the treatment of brain tumors.Bone marrow derived myeloid cells orchestrate antiangiogenic resistance in glioblastoma through coordinated molecular networks.Targeted cancer gene therapy using a hypoxia inducible factor dependent oncolytic adenovirus armed with interleukin-4'Pseudopalisading' necrosis in glioblastoma: a familiar morphologic feature that links vascular pathology, hypoxia, and angiogenesis.Large-volume low apparent diffusion coefficient lesions predict poor survival in bevacizumab-treated glioblastoma patients.Glioblastoma: Defining Tumor Niches.Hypoxia-induced expression of VE-cadherin and filamin B in glioma cell cultures and pseudopalisade structures
P2860
Q24632791-27341934-FB3F-4DFA-A26B-38ECF279101AQ24670606-2C409688-EDF1-44FD-998F-CC59A2B7DBBBQ26781833-309CA045-148D-43AF-8237-C0402CCE5701Q28550489-1A8E3832-439B-417D-A084-0E6821C52585Q33431673-9E36C4C0-2069-4076-8C63-5F14802FA802Q33635374-C391D169-FAAF-4C92-ADDD-1C32BB8D0509Q33656976-0F76B075-CEEF-4636-861A-C364E844A90AQ33677057-68F6BE80-7BD0-4D7E-A653-4896A9DBA6C8Q33759272-EB0CF67F-DA96-46F1-A3F7-F034D974EF05Q33959279-2CEC2EED-CCF0-487A-8EAB-20F27CB1921FQ34176723-5726FBB8-5837-4D0D-A838-D75E958D4C01Q34198939-A96CBE52-822F-4B30-818F-3F1D4D6F12CEQ34218198-8C8E5190-2327-48AA-9FC2-221EE3C4D9F4Q34437996-1D9DB1A2-749A-4CA2-9E95-4FE6F541236FQ34458631-5AD79A44-194F-4480-823E-8CADFC89758EQ34463432-437DFBC4-C36E-4B93-BF20-CE5D34C864AEQ34598854-72D5FBD0-8EF9-4652-8E89-9A6659A27A2FQ34625129-7AE10E6D-A6F9-45EB-8AC3-D52362360473Q34661966-DB0B8F64-6634-4178-B19C-2D77151BA0F6Q35021389-96C3F4A7-8367-48A5-A20F-9EDAFBE0DBB3Q35164701-51051730-438D-43E5-ABE1-567E060391C9Q35392528-B0018506-BA00-41A6-B905-313D3D4F9C41Q35440540-1469E11F-B5D8-4B95-B18B-1E955847D46BQ35450291-D6FED424-945A-4CD0-898E-0A3E462A367EQ35570253-4B67E1A3-7577-45B8-BFE1-4B9A3755A8ECQ35600833-97F0498B-BABF-43D6-898E-5F086B5EB253Q35800467-E7438A34-17FD-40BA-9039-78F5E534BF5EQ35816668-727E4103-CDB3-4BA0-857A-640FBB5CCD81Q35858003-44A73F19-9168-477A-BBDA-071F86A5394EQ35901811-E806708D-6C6B-4141-94B3-2CB040761046Q36208015-548157FC-E910-439A-85FE-21D927EC01D1Q36224819-DDBB20DC-0FD0-4C0C-B337-565CB26D6663Q36225372-1DD2A3BE-304B-4A9E-B493-75C1E51B17A4Q36267243-7D89078D-26D1-4679-9C25-2D686DE75488Q36390700-23A92676-BAEF-45A5-AAF3-19038EBFF691Q36488714-92F84B4D-9648-47F7-9C6E-EB4F545A7282Q36510818-DE4845AE-E00E-4FCD-A8C4-A6DD72C7389BQ36785131-BC787AB4-D10F-467E-A65D-F0AD0AF91D0EQ36796616-5448A1ED-8208-4C0C-8AA1-68D7387B6668Q36849835-6FDA77F6-5A38-4896-B623-B441FB0E83B5
P2860
Vaso-occlusive and prothrombotic mechanisms associated with tumor hypoxia, necrosis, and accelerated growth in glioblastoma.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Vaso-occlusive and prothrombot ...... erated growth in glioblastoma.
@ast
Vaso-occlusive and prothrombot ...... erated growth in glioblastoma.
@en
type
label
Vaso-occlusive and prothrombot ...... erated growth in glioblastoma.
@ast
Vaso-occlusive and prothrombot ...... erated growth in glioblastoma.
@en
prefLabel
Vaso-occlusive and prothrombot ...... erated growth in glioblastoma.
@ast
Vaso-occlusive and prothrombot ...... erated growth in glioblastoma.
@en
P2860
P1476
Vaso-occlusive and prothrombot ...... erated growth in glioblastoma.
@en
P2093
Daniel J Brat
P2860
P2888
P304
P356
10.1038/LABINVEST.3700070
P577
2004-04-01T00:00:00Z